Intensity Therapeutics, Inc. Common stock (INTS) — Strategic Asset Allocation Index
Intensity Therapeutics, Inc. Common stock (INTS) has a Strategic Asset Allocation Index of 3.3% as of December 2019. Strategic assets (PP&E of $252.67K plus long-term investments of $-) total $252.67K, measured against net assets of $7.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Intensity Therapeutics, Inc. Common stock Strategic Asset Allocation Index (2019–2019)
This chart shows how Intensity Therapeutics, Inc. Common stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the index stands at 3.3%, representing strategic assets of $252.67K against net assets of $7.70 Million USD. Explore Intensity Therapeutics, Inc. Common stoc (INTS) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Intensity Therapeutics, Inc. Common stock (2019–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Intensity Therapeutics, Inc. Common stock from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Intensity Therapeutics, Inc. Common stoc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 3.3% | $252.67K | $252.67K | $- | $7.70 Million | — |